No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Optimistic Outlook for Passage Bio Amid Clinical and Financial Progress: Maintains Buy Rating
Passage Bio (PASG) Gets a Buy From TD Cowen
Passage Bio | 10-Q: Quarterly report
Passage Bio Unveils Updated Corporate Presentation
Passage Bio: Cash Runway Into 4Q 2025 >PASG
Passage Bio: Cash Runway Into 4Q 2025 >PASG
Passage Bio 1Q Loss/Shr 30c >PASG
Passage Bio 1Q Loss/Shr 30c >PASG